IMVO | Irish Medicines Verification Organisation
IMVO is Ireland's non-profit regulatory body operating the national medicines verification system (IMVS), authenticating prescription medicines via 2D barcode scanning to protect patients from falsified drugs under EU regulation.
- Company typePrivate
- Founded2017
- HeadquartersDublin 2, Ireland
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What IMVO | Irish Medicines Verification Organisation does
IMVO (Irish Medicines Verification Organisation) is a non-profit company limited by guarantee, established in 2017 and legally mandated under Commission Delegated Regulation (EU) 2016/161 to establish and manage the Irish Medicines Verification System (IMVS) — Ireland's national node of the European Medicines Verification System (EMVS). The organization protects Irish patients from falsified medicines by enabling authentication of prescription medicines at the point of dispense through 2D barcode scanning against unique pack-level identifiers. Its core technology, the IMVS, is operated by technology partner Solidsoft Reply and connects to the EU Hub managed by EMVO, through which marketing authorisation holders upload product data.
IMVO's customer base spans four primary stakeholder groups: community pharmacies, hospitals, pharmaceutical wholesalers, and marketing authorisation holders (MAHs), plus a secondary ecosystem of FMD software providers that integrate with the IMVS. The revenue model is fee-based, with MAHs paying a one-off €1,000 registration fee and annual user fees (with a 60% rebate available for MAHs under €100,000 in Irish turnover), supplemented by subscriptions from IMVO's five founding member organisations. End-user registration for pharmacies, hospitals, and wholesalers is free. Supporting tools include the NMVS Alerts system for alert investigation, the IMVS Portal for account administration, the Emergency Verification Application (EVA) for manual verification, and scanner configuration utilities.
The organization operates from a single Dublin headquarters at 7 Clanwilliam Terrace, with HPRA supervising regulatory compliance and an appointed Independent Chairperson (Paul Reid, from March 2026) overseeing governance. IMVO's recently published Corporate Strategy 2025-2027 signals intent to expand its offering beyond verification operations, while day-to-day activities center on stakeholder webinars, FMD compliance support, and Windsor Framework adaptation in a post-Brexit context.
IMVO | Irish Medicines Verification Organisation firmographics
Firmographics- Name
- IMVO | Irish Medicines Verification Organisation
- Legal name
- Irish Medicines Verification Organisation
- Website
- https://imvo.ie
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- IMVO is Ireland's non-profit regulatory body operating the national medicines verification system (IMVS), authenticating prescription medicines via 2D barcode scanning to protect patients from falsified drugs under EU regulation.
- Ownership category
- akta.pro rank
IMVO | Irish Medicines Verification Organisation industry classification
Industry- Product category
- Pharmaceutical Verification / Medicines Authentication
- NAICS
- Medical and Diagnostic Laboratories (6215)
- SIC
- Services-Testing Laboratories (8734)
- akta.pro primary industry
- Fraud Prevention & Identity Verification (IDV/KYC) (BPAMAEAI)
- akta.pro secondary industry
- Identity & Access Management (IAM) for Healthcare (HLACAJAA)
Keywords
Where IMVO | Irish Medicines Verification Organisation is headquartered
LocationHeadquarters
- HQ city
- Dublin 2
- HQ country
- Ireland
- HQ region
- Europe
Offices1 record
Markets served
IMVO | Irish Medicines Verification Organisation business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Others
Revenue model
- MAH Fees: IMVO is primarily funded by fees charged to marketing authorisation holders (MAHs) whose pack data is contained in the IMVO repository. This includes a one-off registration fee of €1,000 and annual user fees.
- Member Subscriptions: Annual subscriptions paid by founding member organisations represent a small proportion of IMVO's income.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Multi-year contract | MAH Registration Fee |
| Subscription | Annual | Annual MAH User Fee |
| Subscription | Annual | End-user Registration (Pharmacies, Hospitals, Wholesalers) |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
IMVO | Irish Medicines Verification Organisation product offering
Product offeringCore offering
IMVO operates the Irish Medicines Verification System (IMVS), the national platform that verifies the authenticity of prescription medicines in Ireland through 2D barcode scanning as part of the European Medicines Verification System (EMVS). The organisation enables pharmacies, hospitals, wholesalers, and marketing authorisation holders to comply with the EU Falsified Medicines Directive by connecting to a central repository of unique pack identifiers. IMVO also provides the NMVS Alerts system for managing verification exceptions, an Emergency Verification Application (EVA) for manual barcode entry, and onboarding/certification services for FMD software providers.
Product overview
IMVO operates the Irish Medicines Verification System (IMVS) as a single unified platform for verifying prescription medicines authenticity in Ireland, part of the broader European Medicines Verification System (EMVS). The core IMVS enables real-time verification of medicines via 2D barcode scanning, supported by the NMVS Alerts system for alert investigation management and the IMVS Portal for account administration. Additional tools include the Emergency Verification Application (EVA) for manual barcode entry, FMD Software Provider certification services, Operation Code Search for alert diagnostics, and Scanner Configuration tools. The system connects to the EU Hub (managed by EMVO) for cross-border data exchange and is accessed through certified FMD software solutions from third-party providers.
Differentiator
Problem solved
Functional benefit
Products and services
- Irish Medicines Verification System (IMVS) The core national medicines verification system that verifies the authenticity of prescription medicines by scanning 2D barcodes (data matrix codes) containing unique identifiers including product code, serial number, batch number, and expiry date. It is part of the European Medicines Verification System (EMVS) and serves pharmacies, hospitals, wholesalers, and marketing authorisation holders (MAHs) in Ireland.
- NMVS Alerts IMVO's web-based alert management system for efficient handling of alerts generated when medicines are scanned. The tool facilitates quick communication between end-users, MAHs, and IMVO regarding alerts and provides an overview of alert status based on information entered by all parties. Used by pharmacies, hospitals, wholesalers, and MAHs for exception management.
- IMVS Portal Web-based portal for end-users (pharmacies, hospitals, wholesalers) to manage their IMVS account, add/delete locations, generate client credentials (client ID and client secret), add/delete equipment, and update location details. Access requires username, password, and 6-digit authorisation code.
- Emergency Verification Application (EVA) Online manual entry portal for verifying or decommissioning packs when barcode scanning is not possible. Users type in the unique identifier data printed on the pack. Pharmacies can verify and decommission as destroyed, sample, and supplied; wholesalers can verify and decommission as destroyed, sample, supplied, locked, exported, and stolen.
- FMD Software Provider Onboarding & Certification Onboarding and certification process for FMD software providers to connect their solutions to the IMVS. Includes organisation details form, legitimacy checks, and self-certification testing in the IMVS quality environment using an SDK provided by IMVO. Targets software vendors developing dispensing, stock management, and standalone FMD solutions.
Quantifiable outcome
- No counterfeits have been identified to date in Ireland in the legitimate supply chain through FMD scanning
Companies that use IMVO | Irish Medicines Verification Organisation
Customer profileNamed customers5 records
Segments5 records
Ideal customer profiles5 records
IMVO | Irish Medicines Verification Organisation technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature3 records
IMVO | Irish Medicines Verification Organisation partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Solidsoft ReplycoreSolidsoft Reply operates the national medicines verification systems, including the Irish Medicines Verification System (IMVS). They provide the technical infrastructure, SDK, and support for FMD software providers connecting to the system. Technical support is available via service desk Monday-Saturday 08:00-20:00.
Scale indicators1 record
Recent moves6 records
Expansion highlights4 records
IMVO | Irish Medicines Verification Organisation competitors and assessment
Company assessmentEmerging players
- Movilitas: Movilitas provides pharmaceutical serialization and traceability consulting and software solutions that integrate with national medicines verification systems including IMVS. It operates in the adjacent serialization ecosystem serving MAHs and software providers connecting to NMVOs.
Others
- Solidsoft Reply: Solidsoft Reply operates the IMVS technology platform for IMVO and is the technology partner for multiple national medicines verification systems across Europe. It is a key enabling technology vendor rather than a direct competitor.
Broad incumbents
- TraceLink: TraceLink is a major pharmaceutical serialization and supply chain traceability platform that connects MAHs to national verification systems globally including in the EU FMD framework. It is a broad incumbent in the underlying serialization ecosystem IMVO operates within.
- European Medicines Verification Organisation (EMVO): EMVO operates the EU Hub that connects all national medicines verification systems including IMVS. It is the umbrella European-level organisation overseeing the framework that IMVO implements nationally.
- Health Products Regulatory Authority (HPRA): HPRA is Ireland's regulator responsible for supervising IMVO and the IMVS under Commission Delegated Regulation (EU) 2016/161. While broader in scope (covering all health products regulation), it is a key institutional peer in the same pharmaceutical oversight domain.
Direct peers
- SEVeM: SEVeM is the Spanish national medicines verification organisation tasked with operating the Spanish NMVS under EU FMD. It is a directly comparable peer serving the same regulatory function as IMVO.
- France MVO (CIPAM): France MVO operates the French national medicines verification system (NMVS) under the same EU Falsified Medicines Directive framework as IMVO. It is a directly comparable NMVO with the same stakeholder-driven non-profit structure.
- securPharm: securPharm is the German national medicines verification organisation operating the securPharm system for FMD compliance in Germany. It performs the same regulatory mandate as IMVO at a much larger national scale, making it the most directly comparable peer.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
IMVO | Irish Medicines Verification Organisation social profiles
Digital presenceIMVO | Irish Medicines Verification Organisation compliance and trust
Trust signalCompliance2 records
IMVO | Irish Medicines Verification Organisation financial estimates
Financial estimateRevenue estimate
Valuation estimate
IMVO | Irish Medicines Verification Organisation leadership team
Management profileNumber of profiles
Profiles9 records
IMVO | Irish Medicines Verification Organisation funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
IMVO | Irish Medicines Verification Organisation M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about IMVO | Irish Medicines Verification Organisation
What does IMVO | Irish Medicines Verification Organisation do?
IMVO operates the Irish Medicines Verification System (IMVS), the national platform that verifies the authenticity of prescription medicines in Ireland through 2D barcode scanning as part of the European Medicines Verification System (EMVS). The organisation enables pharmacies, hospitals, wholesalers, and marketing authorisation holders to comply with the EU Falsified Medicines Directive by connecting to a central repository of unique pack identifiers. IMVO also provides the NMVS Alerts system for managing verification exceptions, an Emergency Verification Application (EVA) for manual barcode entry, and onboarding/certification services for FMD software providers.
Is IMVO | Irish Medicines Verification Organisation a public or private company?
IMVO | Irish Medicines Verification Organisation is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was IMVO | Irish Medicines Verification Organisation founded?
IMVO | Irish Medicines Verification Organisation was founded in 2017. It employs 11 to 50 people.
Where is IMVO | Irish Medicines Verification Organisation based?
IMVO | Irish Medicines Verification Organisation is headquartered in Dublin 2, Ireland, in the Europe region.
How does IMVO | Irish Medicines Verification Organisation make money?
Two revenue lines are on record. MAH Fees are the primary driver. The others are member Subscriptions.
Who are IMVO | Irish Medicines Verification Organisation's main competitors?
Movilitas is listed as an emerging player. Solidsoft Reply is listed as an others. Broad incumbents are TraceLink, European Medicines Verification Organisation (EMVO) and Health Products Regulatory Authority (HPRA). Direct peers are SEVeM, France MVO (CIPAM) and securPharm.
Does IMVO | Irish Medicines Verification Organisation have an API?
Yes. IMVO provides a Software Development Kit (SDK) to FMD software providers to enable them to create an interface between their FMD software solutions and the IMVS. The SDK allows pharmacies, hospitals, and wholesalers to create electronic connections to the Irish Medicines Verification System. Software providers must complete self-certification tests in the IMVS quality environment using a test book, and the system provider Solidsoft Reply offers technical support via a service desk. Developer documentation is at www.imvo.ie/system-users/fmd-software-providers.
What industry is IMVO | Irish Medicines Verification Organisation in?
IMVO | Irish Medicines Verification Organisation's product category is Pharmaceutical Verification / Medicines Authentication. Its primary akta.pro industry code is BPAMAEAI, Fraud Prevention & Identity Verification (IDV/KYC), with a secondary code of HLACAJAA, Identity & Access Management (IAM) for Healthcare. Its NAICS code is 6215 and its SIC code is 8734.